Vertanical’s Phase 3 win for non-opioid painkiller; Apriori lays off 40% of staff 

Plus, news about Pillar, vTv Therapeutics, OPKO Health, Entera Bio, Zentalis, Sutro Biopharma and Idorsia: Vertanical’s non-opioid painkiller succeeds in Phase 3: The German biotech claimed a late-stage win in chronic back pain for its ...